Japan Cholera Vaccine (Oral Route) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Cholera Vaccine (Oral Route) market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Cholera Vaccine (Oral Route) market. Detailed analysis of key players, along with key growth strategies adopted by Cholera Vaccine (Oral Route) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • PaxVax

    • EuBiologics

    • Sanofi

    • Valneva

    By Type:

    • Shanchol

    • Dukoral

    • Vaxchora

    • Others

    By End-User:

    • Hospital

    • Research & Academic Laboratories

    • Pharmaceutical & Biotechnology Companies

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cholera Vaccine (Oral Route) Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol from 2014 to 2026

      • 1.3.2 Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral from 2014 to 2026

      • 1.3.3 Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora from 2014 to 2026

      • 1.3.4 Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Hospital

      • 1.4.2 Market Size and Growth Rate of Research & Academic Laboratories

      • 1.4.3 Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

      • 1.4.4 Market Size and Growth Rate of Others

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Cholera Vaccine (Oral Route) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cholera Vaccine (Oral Route) by Major Types

      • 3.4.1 Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol from 2014 to 2026

      • 3.4.2 Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral from 2014 to 2026

      • 3.4.3 Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora from 2014 to 2026

      • 3.4.4 Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

    4 Segmentation of Cholera Vaccine (Oral Route) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cholera Vaccine (Oral Route) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Hospital

      • 4.4.2 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Research & Academic Laboratories

      • 4.4.3 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Pharmaceutical & Biotechnology Companies

      • 4.4.4 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Others

    5 Market Analysis by Regions

    • 5.1 Japan Cholera Vaccine (Oral Route) Production Analysis by Regions

    • 5.2 Japan Cholera Vaccine (Oral Route) Consumption Analysis by Regions

    6 Hokkaido Cholera Vaccine (Oral Route) Landscape Analysis

    • 6.1 Hokkaido Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 6.2 Hokkaido Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    7 Tohoku Cholera Vaccine (Oral Route) Landscape Analysis

    • 7.1 Tohoku Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 7.2 Tohoku Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    8 Kanto Cholera Vaccine (Oral Route) Landscape Analysis

    • 8.1 Kanto Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 8.2 Kanto Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    9 Chubu Cholera Vaccine (Oral Route) Landscape Analysis

    • 9.1 Chubu Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 9.2 Chubu Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    10 Kinki Cholera Vaccine (Oral Route) Landscape Analysis

    • 10.1 Kinki Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 10.2 Kinki Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    11 Chugoku Cholera Vaccine (Oral Route) Landscape Analysis

    • 11.1 Chugoku Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 11.2 Chugoku Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    12 Shikoku Cholera Vaccine (Oral Route) Landscape Analysis

    • 12.1 Shikoku Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 12.2 Shikoku Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    13 Kyushu Cholera Vaccine (Oral Route) Landscape Analysis

    • 13.1 Kyushu Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 13.2 Kyushu Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 PaxVax

      • 14.1.1 PaxVax Company Profile and Recent Development

      • 14.1.2 PaxVax Market Performance

      • 14.1.3 PaxVax Product and Service Introduction

    • 14.2 EuBiologics

      • 14.2.1 EuBiologics Company Profile and Recent Development

      • 14.2.2 EuBiologics Market Performance

      • 14.2.3 EuBiologics Product and Service Introduction

    • 14.3 Sanofi

      • 14.3.1 Sanofi Company Profile and Recent Development

      • 14.3.2 Sanofi Market Performance

      • 14.3.3 Sanofi Product and Service Introduction

    • 14.4 Valneva

      • 14.4.1 Valneva Company Profile and Recent Development

      • 14.4.2 Valneva Market Performance

      • 14.4.3 Valneva Product and Service Introduction

     

    The List of Tables and Figures (Totals 110 Figures and 189 Tables)

    • Figure Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol from 2014 to 2026

    • Figure Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral from 2014 to 2026

    • Figure Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora from 2014 to 2026

    • Figure Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Research & Academic Laboratories

    • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

    • Figure Market Size and Growth Rate of Others

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cholera Vaccine (Oral Route) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cholera Vaccine (Oral Route)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cholera Vaccine (Oral Route) by Different Types from 2014 to 2026

    • Table Consumption Share of Cholera Vaccine (Oral Route) by Different Types from 2014 to 2026

    • Figure Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol from 2014 to 2026

    • Figure Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral from 2014 to 2026

    • Figure Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora from 2014 to 2026

    • Figure Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cholera Vaccine (Oral Route) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cholera Vaccine (Oral Route) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Research & Academic Laboratories

    • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

    • Figure Market Size and Growth Rate of Others

    • Table Japan Cholera Vaccine (Oral Route) Production by Regions

    • Table Japan Cholera Vaccine (Oral Route) Production Share by Regions

    • Figure Japan Cholera Vaccine (Oral Route) Production Share by Regions in 2014

    • Figure Japan Cholera Vaccine (Oral Route) Production Share by Regions in 2018

    • Figure Japan Cholera Vaccine (Oral Route) Production Share by Regions in 2026

    • Table Japan Cholera Vaccine (Oral Route) Consumption by Regions

    • Table Japan Cholera Vaccine (Oral Route) Consumption Share by Regions

    • Figure Japan Cholera Vaccine (Oral Route) Consumption Share by Regions in 2014

    • Figure Japan Cholera Vaccine (Oral Route) Consumption Share by Regions in 2018

    • Figure Japan Cholera Vaccine (Oral Route) Consumption Share by Regions in 2026

    • Table Hokkaido Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Hokkaido Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

    • Figure Hokkaido Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

    • Figure Hokkaido Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

    • Table Hokkaido Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

    • Figure Hokkaido Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

    • Figure Hokkaido Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

    • Table Tohoku Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Tohoku Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

    • Figure Tohoku Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

    • Figure Tohoku Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

    • Table Tohoku Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Tohoku Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

    • Figure Tohoku Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

    • Figure Tohoku Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

    • Table Kanto Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Kanto Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Figure Kanto Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

    • Figure Kanto Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

    • Figure Kanto Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

    • Table Kanto Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Kanto Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

    • Figure Kanto Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

    • Figure Kanto Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

    • Table Chubu Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Chubu Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Figure Chubu Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

    • Figure Chubu Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

    • Figure Chubu Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

    • Table Chubu Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Chubu Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

    • Figure Chubu Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

    • Figure Chubu Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

    • Table Kinki Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Kinki Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Figure Kinki Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

    • Figure Kinki Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

    • Figure Kinki Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

    • Table Kinki Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Kinki Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

    • Figure Kinki Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

    • Figure Kinki Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

    • Table Chugoku Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Chugoku Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

    • Figure Chugoku Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

    • Figure Chugoku Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

    • Table Chugoku Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Chugoku Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

    • Figure Chugoku Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

    • Figure Chugoku Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

    • Table Shikoku Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Shikoku Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

    • Figure Shikoku Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

    • Figure Shikoku Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

    • Table Shikoku Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Shikoku Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

    • Figure Shikoku Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

    • Figure Shikoku Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

    • Table Kyushu Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Kyushu Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Cholera Vaccine (Oral Route) Consumption Share by Types in 2014

    • Figure Kyushu Cholera Vaccine (Oral Route) Consumption Share by Types in 2018

    • Figure Kyushu Cholera Vaccine (Oral Route) Consumption Share by Types in 2026

    • Table Kyushu Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Kyushu Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2014

    • Figure Kyushu Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2018

    • Figure Kyushu Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of PaxVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PaxVax

    • Figure Sales and Growth Rate Analysis of PaxVax

    • Figure Revenue and Market Share Analysis of PaxVax

    • Table Product and Service Introduction of PaxVax

    • Table Company Profile and Development Status of EuBiologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EuBiologics

    • Figure Sales and Growth Rate Analysis of EuBiologics

    • Figure Revenue and Market Share Analysis of EuBiologics

    • Table Product and Service Introduction of EuBiologics

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Valneva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva

    • Figure Sales and Growth Rate Analysis of Valneva

    • Figure Revenue and Market Share Analysis of Valneva

    • Table Product and Service Introduction of Valneva

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.